Spanish Red Biotech Pipeline

MSD

Pembrolizumab

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: First Line Study of Pembrolizumab +/- Ipilimumab in NSCLC
Phase: 3Phase III in Spain, 2Phase II, 1Phase I in Spain